Ballicules.com

Linaclotide

LINZESS

Pronunciation: lin-AK-loe-tide (lin-ZES)

Linaclotide ballicule: receptor binding, kinetics and half-life diagram
Mechanism of action: Linaclotide ballicule
Linaclotide LINZESS mascot mnemonic cartoon
Visual mnemonic: Linaclotide mascot
“Linus’ Linen cloth”

What it isGuanylate cyclase-C agonist that increases intestinal fluid secretion; IBS-C and chronic idiopathic constipation.

Why this oneUnlike plecanatide, food amplifies its gastrointestinal effects, so it is taken on an empty stomach.

What limits itDiarrhea is dose-limiting; it is contraindicated under age 2, and severe cases require stopping and rehydration.

Linaclotide molecular structure (skeletal formula)
Molecular structure: Linaclotide

FDA-approved for

FDA label

BOXED WARNING Contraindicated in patients <2 years of age; in neonatal mice a single clinically relevant adult dose caused death from dehydration.
FDA dosingPopulationStartTargetMax
Irritable bowel syndrome with constipation (IBS-C)Adults290 mcg QD290 mcg QD290 mcg QD
Chronic idiopathic constipation (CIC)Adults145 mcg QD (72 mcg QD by presentation/tolerability)145 mcg QD145 mcg QD
IBS-CPediatric >=7 yr145 mcg QD145 mcg QD145 mcg QD
Functional constipation (FC)Pediatric >=2 yr72 mcg QD72 mcg QD72 mcg QD

Renal Undefined

Hepatic Undefined

Instructions

Available strengths

Contraindications

Cautions

Adverse reactions

Pregnancy Negligible systemic absorption; maternal use not expected to result in fetal exposure; human data insufficient.

Lactation Not detected in human milk; not expected to expose the breastfed infant.

Cost

Linaclotide (LINZESS)
What pharmacies pay · NADAC 9/30/26
Strength#/mogeneric $/mobrand $/moCostPlus
72 mcgcap30 qd—$270.32not offered
145 mcgcap30 qd—$270.60not offered
290 mcgcap30 qd—$270.46not offered

Generic entry2021

⚠ BOXED WARNING

Principal riskDiarrhea; contraindicated under age 2

Classes and tags

Clinical profile

Therapeutic safety burden0 / 4
Overdose danger0 / 4
Weight-gain liability0 / 4
Sedation liability0 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk0 / 4

Legacy pregnancy categoryUnknown / historical label unavailable

Defining liabilityLocal irritation, sensitization or administration-site injury; negligible systemic toxicity at usual use.

Open Linaclotide in the interactive console ↗

Memory aids: interaction avatars

Linaclotide no kinetic interactions avatar mnemonic
no kinetic interactions

Open Linaclotide in the interactive console ↗